Please login to the form below
Cellectis
This page shows the latest Cellectis news and features for those working in and with pharma, biotech and healthcare.
Daily Brief: Cellectis gains Novartis scientist, EU label updates for Janssen and Otsuka
Daily Brief: Cellectis gains Novartis scientist, EU label updates for Janssen and Otsuka. ... The latest from pharma, biotech and healthcare. Cellectis gains senior scientist from Novartis.
Latest news
-
Sangamo bulks up in cell therapy with TxCell acquisition
Other techniques include CRISPR/Cas9 - used by Novartis and Juno - and Cellectis’favoured TALENS.
-
Gilead signs $3bn-plus gene-editing deal with Sangamo
The deal with Sangamo means rivals in the CAR-T category such asand off-the-shelf specialist Cellectis won’t be able to use the ZFN technology in their own ... Other techniques include CRISPR/Cas9 - used by Novartis and Juno - and Cellectis’favoured
-
Cellectis floored by patient death in CAR-T trial
Cellectis floored by patient death in CAR-T trial. FDA puts two cancer immunotherapy trials on hold. ... It may be that the FDA will exercise greater caution in Cellectis' case.
-
Servier cleared to start US trials CAR-T therapy
The French pharma company entered the race to develop chimeric antigen receptor therapies (CAR-T) for cancer after it acquired exclusive rights to UCART19 from Cellectis in 2015. ... Cellectis specialises in the development of ‘off-the-shelf’CAR-T
-
Cellectis gets FDA nod for 'off-the-shelf' CAR-T trial
Cellectis gets FDA nod for 'off-the-shelf' CAR-T trial. Investigational New Drug gets go-ahead for trials in patients with two haematological cancers. ... This is not the first time that one of Cellectis' CAR-T candidates has been tested in patients
More from news
Approximately 9 fully matching, plus 10 partially matching documents found.
Latest Intelligence
-
Deal Watch November 2015
379. Cellectis. Servier. Option exercise. UCART19, CAR-T allogeneic immunotherapy being tested for chronic lymphocytic leukaemia and acute lymphoblastic leukaemia.
-
Pharma deals in May 2015
Following the collaboration announced in June 2014 with Cellectis, the rumours are now going around that Pfizer may be planning an acquisition with an estimated price tag of $1.6bn.
-
Pharma deals in March 2015
Also Evaluate reports a cautious approach by big pharma. Novartis, J&J and Pfizer (via a deal with Cellectis) are in the go-kart race but other companies such as Merck
-
Pharma deals during June 2014
Cellectis has reserved 12 other targets and Pfizer will provide preclinical development assistance for four of these. ... easily. Cellectis plans to open a research site in the US to work more closely with Pfizer.
-
Deal Watch table for June 2014
350. Medreich/ Meiji Seika. Company acquisition. India-based manufacturing company. 290. Cellectis/ Pfizer.
More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.
Latest appointments
-
Zelluna Immunotherapy appoints chief technology officer
Arjan Roozen, who previously headed up the GMP solutions and manufacturing team at French cell therapy group Cellectis, comes with expertise in microbiology and molecular microbiology.
-
Cellectis’ Mathieu Simon will serve as interim chief medical officer
Cellectis’ Mathieu Simon will serve as interim chief medical officer. He will take over the responsibilities of Loan Hoang-Sayag. ... Cellectis has appointed Mathieu Simon to as interim chief medical officer, taking over the role from Loan Hoan-Sayag,
-
Rainer Boehm and Hervé Hoppenot join Cellectics board
I see exciting opportunities for Cellectis to address unmet medical needs and make a meaningful difference in people’s lives. ... I am excited to be joining the Cellectis board during this important time of growth.”.
-
Dr Niall Murphy and Pierre Schwich join Pharnext
Meanwhile, Pierre Schwich (pictured left) joins Pharnext from Cellectis where he served as chief financial officer from 2011 until 2014. ... Before joining Cellectis, he served as chief financial officer and corporate secretary for Genesys Conferencing,
More from appointments
Approximately 1 fully matching, plus 3 partially matching documents found.
Featured jobs
-
Account Manager / Account Director
-
Competative
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
-
New Business Director - PR
-
Competitive Salary and benefits
-
Medical/ Scientific Director
-
Salary TBC
- Account Manager / Senior Account Manager
-
35, 000-40, 000
- Senior Medical Writer (Remote Working)
-
Competitive Salary Offered
- Programme Director, Healthcare PR, Highly competitive package
-
Highly Competitive package
- Senior Account Director development role to Business Director, H...
-
Excellent package
- Events Manager – Med Comms – Surrey
-
Salary TBC
-
Account Director
-
£48, 000 - £60, 000
-
Medical Writers
-
Competitive Salary and Benefits
-
Account Director
-
Excellent benefits
- Scientific Director / Editorial Team Leader
-
Great salary and benefits
- Digital Manager, London – Healthcare Brandcomms, Medcomms, PR
-
Excellent package
- Director, Market Access / HEOR - North-West
-
Negotiable
- Senior Account Managers - Oxfordshire
-
Attractive salary and benefits package offered
-
Associate Director
-
£75, 000-90, 000
- Leadership opportunity, Pricing & Market Access, UK, Substan...
-
Substantial six figure package
Subscribe to our email news alerts
- Behaviour change: what is the buzz all about?
- Worldwide Clear Aligner Market to grow at a CAGR of 16.15% By 2023
- Worldwide Prenatal and New-born Genetic Testing Market Set to Register 11.9% CAGR During 2018-2024
- Medical Biomimetics Market soaring at 5.5% CAGR to Hit USD 34.4 Billion By 2024
- Medical Marijuana Market to Soar at 36% CAGR to 2024
- Worldwide Medical Ultrasound Imaging Equipment Market to Witness Robust Expansion Throughout the Forecast Period 2018 – 2023
PMHub
Wisepress
Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...
Latest intelligence
- OUTiCO win Best in UK Pharmaceutical Outsourcing award
- The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
- Artificial Intelligence in Healthcare
- Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
- World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
- Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
Quick links
Infographics
